-related maternal mortality, and late maternal death.
Secondary analyses then allowed systematic examination
SEREDA, Y.,
KIRIAZOVA, T.,
MAKARENKO, O.,
CARROLL, J.J.,
RYBAK, N.,
GILLANI, F.S.,
FLANIGAN, T.,
CHYBISOV, A.,
BENDIKS, S.,
DUTTA, A.,
SAMET, J.H.,
LUNZE, K.,
IDRISOV, B. (2020) (Substance Abuse Stigma Scale) and intersectional stigma (both stigma forms above 75th percentile).
SecondaryCHROMCHENKOVA, E.P.,
BOKOV, D.O.,
BESSONOV, V.V.,
SAMYLINA, I.A.,
KAKHRAMANOVA, S.D.,
CHEVIDAEV, V.V.,
SOKHIN, D.M.,
BALOBANOVA, N.P.,
EVGRAFOV, A.A.,
KRASNYUK, J.I.,
KUDASHKINA, N.V.,
GALIAKHMETOVA, E.K.,
MARAKHOVA, A.I.,
MOISEEV, D.V. (2020) of primary amines) and with fluorenylmethyloxycarbonyl (FMOC) (
secondary amines). The sources of scientific
LIU, Z.,
ZHANG, R.,
CHEN, X.,
YAO, P.,
YAN, T.,
LIU, W.,
YAO, J.,
ZHAO, S.,
SOKHATSKII, A.,
GAREEV, I. (2019) are closely related to
secondary brain injury induced by ICH. RT-qPCR results showed that the expression
Idrisov, Bulat,
Lunze, Karsten,
Cheng, Debbie M.,
Elena Blokhina,
Gnatienko, Natalia,
Quinn, Emily,
Bridden, Carly,
Walley, Alexander Y.,
Bryant, Kendall J.,
Lioznov, Dmitry,
Krupitsky, Evgeny,
Samet, Jefrey H. (2017) was linkage to HIV care within 12 months. Other outcomes were prescription of ART (
secondary)
and achievement
Boykо, A.,
Fernández, O.,
Alifirova, V.,
Babicheva, N.,
Bakhtiyarova, K.,
Volkov, A.,
Glavinskaya, N.,
Goncharova, Z.,
Greshnova, I.,
Smagina, I.,
Lashch, N.,
Inzhinova, A. (2021) -remitting (RRMS),
secondary progressive (SPMS), and primary progressive (PPMS) multiple sclerosis. Results
Wu, Hongjie,
Beylerli, Ozal,
Gareev, Ilgiz,
Beilerli, Aferin,
Ilyasova, Tatiana,
Talybov, Rustam,
Sufianov, Albert,
Guo, Xiaolong (2023) determined. Up to 30% of adult patients with cancer of one localization or another suffer from a
secondaryBovell-Ammon, B.J.,
Kimmel, S.D.,
Cheng, D.M.,
Truong, V.,
Michals, A.,
Vetrova, M.,
Hook, K.,
Idrisov, B.,
Blokhina, E.,
Krupitsky, E.,
Samet, J.H.,
Lunze, K. (2023) incarceration and two
secondary outcomes: HIV stigma score (11-item abbreviated Berger scale) and substance use
Bikbov, Mukharram M.,
Kazakbaeva, Gyulli M.,
Panda-Jonas, Songhomitra,
Lakupova, Ellina M.,
Fakhretdinova, Albina A.,
Tuliakova, Azaliia M.,
Jonas, Jost B. (2024) .2%), glaucoma (13.9%), and
secondary cataract (5.4%). Causes for blindness were AMD (24.5%), glaucoma (18